newsfilter
← Latest News
GlobeNewswire·

Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

MALVERN, Pa., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the "Company" or "Baudax Bio") (NASDAQ:BXRX), a biotechnology company focused on developing T cell receptor ("TCR") therapies utilizing human regulatory